Found: 24
Select item for more details and to access through your institution.
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 2833, doi. 10.1007/s00432-022-04159-y
- By:
- Publication type:
- Article
Multiethnic Investigation of Risk and Immune Determinants of COVID-19 Outcomes.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.933190
- By:
- Publication type:
- Article
Inherited cancer predisposing mutations in patients with therapy‐related myeloid neoplasms.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 4, p. 489, doi. 10.1111/bjh.18543
- By:
- Publication type:
- Article
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
- By:
- Publication type:
- Article
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
- By:
- Publication type:
- Article
Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1893, doi. 10.1007/s00262-023-03381-y
- By:
- Publication type:
- Article
Gene networks that compensate for crosstalk with crosstalk.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12021-y
- By:
- Publication type:
- Article
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 186, doi. 10.3390/cancers14010186
- By:
- Publication type:
- Article
Genomic Determinants of Homologous Recombination Deficiency across Human Cancers.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4572, doi. 10.3390/cancers13184572
- By:
- Publication type:
- Article
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1862, doi. 10.3390/cancers12071862
- By:
- Publication type:
- Article
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
- Published in:
- Liver International, 2023, v. 43, n. 3, p. 695, doi. 10.1111/liv.15502
- By:
- Publication type:
- Article
Author response to “Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients”.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
- Published in:
- Liver International, 2018, v. 38, n. 5, p. 895, doi. 10.1111/liv.13613
- By:
- Publication type:
- Article
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 583, doi. 10.1159/000519108
- By:
- Publication type:
- Article
Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 22, p. 8571, doi. 10.1002/cam4.3457
- By:
- Publication type:
- Article
Prediction of individual COVID-19 diagnosis using baseline demographics and lab data.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93126-7
- By:
- Publication type:
- Article
An Electronic Best Practice Alert Based on Choosing Wisely Guidelines Reduces Thrombophilia Testing in the Outpatient Setting.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Management of de novo metastatic hormone-sensitive prostate cancer: A comprehensive report of a single-center experience.
- Published in:
- PLoS ONE, 2022, v. 17, n. 8, p. 1, doi. 10.1371/journal.pone.0264800
- By:
- Publication type:
- Article
Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 366, doi. 10.1093/oncolo/oyac224
- By:
- Publication type:
- Article
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. 432, doi. 10.1093/oncolo/oyab075
- By:
- Publication type:
- Article
A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 4, p. n/a, doi. 10.1111/tid.12728
- By:
- Publication type:
- Article
Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti‐viral therapy in patients with chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1128, doi. 10.1111/apt.15006
- By:
- Publication type:
- Article
EMPHASIZING ORAL HEALTH CARE.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
A protected time policy to improve dental health among resident physicians.
- Published in:
- Journal of the American Dental Association (JADA), 2019, v. 150, n. 5, p. 362, doi. 10.1016/j.adaj.2018.12.016
- By:
- Publication type:
- Article